2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$4.77+$0.11 (+2.34%)
Price as of Jul 14, 2026 4:00 AM EDT- $948.2MMarket Cap
- 43.98%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$4.77+$0.11 (+2.34%)
ABUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.67 | ||
Change | -$0.13 (-2.81%) | ||
Open | $4.79 | ||
High | $4.85 | ||
Low | $4.66 | ||
Previous Close | $4.80 | ||
Volume | 1,350,318 | ||
30-Day Average Volume | 3,170,576 | ||
1-Week Change | -6.14% | ||
1-Month Change | 9.51% | ||
1-Year Change | 43.98% | ||
3-Year Change | 105.51% | ||
5-Year Change | 64.26% | ||
Fundamentals | |||
Shares Outstanding | 197.5M | ||
Total Assets | $277.2M | ||
Market Cap | $948.2M | ||
Enterprise Value | $924.5M | ||
Period: QTR TTM FY | |||
Revenue | $204,000.00 | ||
Net Income | $169.7M | ||
Free Cash Flow | -$8.1M | ||
EBIT | $169.7M | ||
EBITDA | $169.7M | ||
Net Working Capital | $271.9M | ||
EPS | $0.87 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | 4,532 | ||
P/B | 4 | ||
P/E | 6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -117 | ||
Price/Operating Cash Flow | -117 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue